HYPOXIMUNE Trademark

Trademark Overview

On Tuesday, July 21, 2020, a trademark application was filed for HYPOXIMUNE with the United States Patent and Trademark Office. The USPTO has given the HYPOXIMUNE trademark a serial number of 90065713. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 24, 2023. This trademark is owned by Therapeutic Solutions International, Inc.. The HYPOXIMUNE trademark is filed in the Pharmaceutical Products category with the following description:

Nutraceuticals for use as a dietary supplement
hypoximune

General Information

Serial Number90065713
Word MarkHYPOXIMUNE
Filing DateTuesday, July 21, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 24, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 27, 2020

Trademark Statements

Goods and ServicesNutraceuticals for use as a dietary supplement

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 19, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTherapeutic Solutions International, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressOceanside, CA 92056
Party NameTherapeutic Solutions International, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressOceanside, CA 92056

Trademark Events

Event DateEvent Description
Monday, July 24, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 24, 2023ABANDONMENT - NO USE STATEMENT FILED
Tuesday, December 13, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 9, 2022SOU EXTENSION 4 GRANTED
Friday, December 9, 2022SOU EXTENSION 4 FILED
Friday, December 9, 2022TEAS EXTENSION RECEIVED
Saturday, June 18, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 16, 2022SOU EXTENSION 3 GRANTED
Thursday, June 16, 2022SOU EXTENSION 3 FILED
Thursday, June 16, 2022TEAS EXTENSION RECEIVED
Saturday, December 18, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 16, 2021SOU EXTENSION 2 GRANTED
Thursday, December 16, 2021SOU EXTENSION 2 FILED
Thursday, December 16, 2021TEAS EXTENSION RECEIVED
Thursday, June 24, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 22, 2021SOU EXTENSION 1 GRANTED
Tuesday, June 22, 2021SOU EXTENSION 1 FILED
Tuesday, June 22, 2021TEAS EXTENSION RECEIVED
Tuesday, December 22, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 15, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 15, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, December 15, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 27, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 27, 2020PUBLISHED FOR OPPOSITION
Wednesday, October 7, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, September 21, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 18, 2020ASSIGNED TO EXAMINER
Wednesday, August 19, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 24, 2020NEW APPLICATION ENTERED

Related Keywords

hypoximune supplement dietary nutraceuticals